Launxp Biomedical Co (ROCO:6876) Change In Inventory : NT$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Launxp Biomedical Co Change In Inventory?

Launxp Biomedical Co's change in inventory for the quarter that ended in Dec. 2024 was NT$0.00 Mil. It means Launxp Biomedical Co's inventory stayed the same from Jun. 2024 to Dec. 2024 .

Launxp Biomedical Co's change in inventory for the fiscal year that ended in Dec. 2024 was NT$0.00 Mil. It means Launxp Biomedical Co's inventory stayed the same from Dec. 2023 to Dec. 2024 .

Launxp Biomedical Co's Total Inventories for the quarter that ended in Dec. 2024 was NT$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Launxp Biomedical Co's Days Inventory for the quarter that ended in Dec. 2024 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Launxp Biomedical Co Change In Inventory Historical Data

The historical data trend for Launxp Biomedical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Launxp Biomedical Co Change In Inventory Chart

Launxp Biomedical Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

0.40

Launxp Biomedical Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial				-	-	-	-	-

Launxp Biomedical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

Launxp Biomedical Co (ROCO:6876) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Launxp Biomedical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.199	*	365 / 2
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Launxp Biomedical Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.199	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Launxp Biomedical Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Launxp Biomedical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Launxp Biomedical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Launxp Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Launxp Biomedical Co Ltd (ROCO:6876) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408

Website

https://www.launxp.com

Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.

Launxp Biomedical Co Headlines

No Headlines